|
|
IRON-HFpEF - Iron substitution with ferric carboxymaltose as treatment strategy for heart failure patients with preserved ejection fraction: A prospective, double-blind placebo-controlled trial
| Project funded by own resources |
| Project title |
IRON-HFpEF - Iron substitution with ferric carboxymaltose as treatment strategy for heart failure patients with preserved ejection fraction: A prospective, double-blind placebo-controlled trial |
| Principal Investigator(s) |
Dieterle, Thomas
|
| Project Members |
Bösing, Maria
Thesenvitz, Elke
Brighenti-Zogg, Stefanie
Mundwiler, Jonas
|
| Organisation / Research unit |
Faculty of Medicine,
Departement Klinische Forschung,
Bereich Medizinische Fächer (Klinik),
Bereich Medizinische Fächer (Klinik) / Allgemeine innere Medizin Liestal (Leuppi) |
| Project start |
27.05.2019 |
| Probable end |
30.06.2021 |
| Status |
Completed |
| Abstract |
IRON-HFpEF is a prospective, double-blind, placebo-controlled trial that investigates the function and structural effects of iron substitution with ferric carboxymaltose on the cardiovascular system in heart failure patients with preserved ejection fraction. |
| Financed by |
Other funds
|
| |
|
|
MCSS v5.8 PRO. 0.406 sec, queries - 0.000 sec
©Universität Basel | Impressum
|  |
|
24/04/2024
Research Database / FORSCHUNGSDATENBANK
|
